Latest Articles on Lung Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all lung cancer cases. Find out more about testing and treatment here.
Read more
Lung Cancer
Breaking prejudice in lung cancer
“Did you smoke?”: Time to rethink the impact of this question on lung cancer patients.
Read more
Lung Cancer
Our goal of transforming the treatment of neuroendocrine carcinomas
Our progress in developing a potential DLL3 targeted immunotherapy for neuroendocrine carcinomas (NECs), including small cell lung cancer (SCLC), large cell NEC of the lung (LC-NEC-L) and extrapulmonary NEC (epNEC).
Read more
Related Press Releases
September 09, 2024
Zongertinib shows encouraging efficacy and tolerability profile in lung cancer patients
August 27, 2024
Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC
Links
Welcome to InOncology.com
A knowledge hub providing information and education in oncology for healthcare professionals.
Nintedanib (Vargatef) in Oncology
A treatment for adenocarcinoma
Afatinib (Giotrif)
A treatment for EGFR M+ NSCLC
Downloads
Nintedanib in Oncology
Explore nintedanib’s mode of action and role in the treatment of lung cancer (PDF).